COVID-19 Vaccines Safety Tracking (CoVaST)

Description

This project aims to monitor the side effects of COVID-19 vaccines worldwide actively. The primary objectives of the project include a) to estimate the prevalence of each local and systemic side effect of each COVID-19 vaccine among healthcare workers (HCW), old adults over +65 (OA), and schoolteachers (ST); b) to evaluate the potential demographic and medical risk factors for side effects frequency and intensity; c) to evaluate the long-term consequences of COVID-19 vaccines. The secondary objectives include a) to evaluate the relative safety of COVID-19 vaccines compared to each other; b) to evaluate the impact of palliative drugs used by the recently vaccinated individuals on their short-term side effects resolution.

Conditions

Adverse Reaction to Vaccine, COVID19 Vaccine

Study Overview

Study Details

Study overview

This project aims to monitor the side effects of COVID-19 vaccines worldwide actively. The primary objectives of the project include a) to estimate the prevalence of each local and systemic side effect of each COVID-19 vaccine among healthcare workers (HCW), old adults over +65 (OA), and schoolteachers (ST); b) to evaluate the potential demographic and medical risk factors for side effects frequency and intensity; c) to evaluate the long-term consequences of COVID-19 vaccines. The secondary objectives include a) to evaluate the relative safety of COVID-19 vaccines compared to each other; b) to evaluate the impact of palliative drugs used by the recently vaccinated individuals on their short-term side effects resolution.

COVID-19 Vaccines Safety Tracking: Global Consortium Study

COVID-19 Vaccines Safety Tracking (CoVaST)

Condition
Adverse Reaction to Vaccine
Intervention / Treatment

-

Contacts and Locations

Philadelphia

American College of Physicians, Philadelphia, Pennsylvania, United States, 19106

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * HCW, OA and ST who received COVID-19 vaccine.
  • * Participating subjects should be at least 18-year-old and able to give their informed consent independently.
  • * Non HCW, OA and ST who received the COVID-19.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Masaryk University,

Study Record Dates

2026-12-31